Hospice Care in Evansville, IN
5 Hospice found. Showing 1 - 5
 Deaconess Vna Medicare Approved Location: 610 E Walnut St, Evansville, Indiana 47734 Phone: (812) 425-3561 |
Kindred Hospice Medicare Approved Location: 323 Metro Ave, Evansville, Indiana 47715 Phone: (812) 476-8990 |
Medical Services Of America Hospice Medicare Approved Location: 3101 North Green River Road, Suite 210, Evansville, Indiana 47715 Phone: (812) 468-0000 |
Heritage Hospice Inc Medicare Approved Location: 1202 W Buena Vista Rd Ste 107, Evansville, Indiana 47710 Phone: (812) 475-9712 |
Aseracare Hospice Medicare Approved Location: 1401 Professional Blvd Suite 201, Evansville, Indiana 47714 Phone: (812) 858-1032 |
News Archive
ADRB receptors play a direct role in Src activation by PKA-mediated mechanism
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
Microbiome researcher Martin J. Blaser earns GUMC's Cura Personalis Award
Georgetown University Medical Center will bestow its highest honor, the Cura Personalis Award, upon Martin J. Blaser, MD, a world-renowned microbiome researcher and clinician.
Researchers identify protein that promotes growth of brain cells damaged by MS
Vittorio Gallo, PhD, Director of the Center for Neuroscience Research at Children's National Health System, and other researchers have found a "potentially novel therapeutic target" to reduce the rate of deterioration and to promote growth of brain cells damaged by multiple sclerosis (MS). Current therapies can be effective in patients with relapsing MS, but have little impact in promoting tissue growth.
Studies offer hope for developing new biomarker and drug for neurodegenerative diseases
Two new studies of progressive, neurodegenerative diseases linked to defects in cells' mitochondria offer hope for developing a new biomarker for research and diagnostics, and a drug for treating such diseases, report researchers at the University of California, Davis.
Oramed starts patient recruitment in Israel for ORMD-0801 clinical trial for patients with T1DM
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that it has initiated patient recruitment for a new clinical trial of its orally ingestible insulin capsule, ORMD-0801 for patients with type 1 diabetes mellitus in Israel.
› Verified 5 days ago